Curis Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	3.04	4.18	1.52	1.11	1.16
Cash & Short-Term Investments	3.04	4.18	1.52	1.11	1.16
Cash Growth	-27.28%	174.13%	37.33%	-4.64%	103.20%
Accounts Receivable	75.24	100.96	95.46	62.44	63.03
Other Receivables	20.45	18.68	22.75	29.61	0.07
Receivables	95.68	119.64	118.2	92.12	63.36
Inventory	184	89.62	51.08	53.75	29.36
Prepaid Expenses	8.97	0.43	0.52	0.77	0.25
Other Current Assets	21.24	7.24	2.43	1.03	30.88
Total Current Assets	312.93	221.1	173.75	148.78	125.01
Property, Plant & Equipment	110.1	115.92	121.98	123.34	126.99
Long-Term Investments	0.05	0.05	0.05	0.05	0.05
Long-Term Deferred Tax Assets	-	-	-	-	6.59
Other Long-Term Assets	2.27	1.7	1.7	1.82	1.82
Total Assets	425.35	338.76	297.48	273.99	260.46
Accounts Payable	51.61	62.29	101.56	85.35	57.7
Accrued Expenses	18.86	13.73	16.79	17.03	6.65
Short-Term Debt	71.56	71.31	50.88	36	35.83
Current Portion of Long-Term Debt	9.63	12.57	13.3	16.19	14.55
Current Income Taxes Payable	22.71	15.56	-	-	-
Other Current Liabilities	1.4	6.57	3.07	3.55	4.37
Total Current Liabilities	175.77	182.03	185.6	158.12	119.09
Long-Term Debt	74.99	87.01	97.75	124.05	155.49
Pension & Post-Retirement Benefits	1.45	0.2	0.16	0.1	-
Long-Term Deferred Tax Liabilities	10.87	10.79	3.9	0.75	-
Other Long-Term Liabilities	-0	-	-	-	-0
Total Liabilities	263.07	280.04	287.42	283.02	274.58
Common Stock	59.34	5	5	5	5
Additional Paid-In Capital	42.1	-	-	-	-
Retained Earnings	60.83	53.73	5.06	-14.04	-19.12
Comprehensive Income & Other	0	-	-	-	-
Shareholders' Equity	162.28	58.73	10.06	-9.04	-14.12
Total Liabilities & Equity	425.35	338.76	297.48	273.99	260.46
Total Debt	156.18	170.89	161.93	176.24	205.86
Net Cash (Debt)	-153.14	-166.72	-160.41	-175.13	-204.7
Net Cash Per Share	-25.81	-28.28	-27.21	-31.84	-37.22
Filing Date Shares Outstanding	5.93	5.5	5.5	5.5	5.5
Total Common Shares Outstanding	5.93	5.5	5.5	5.5	5.5
Working Capital	137.16	39.07	-11.86	-9.34	5.92
Book Value Per Share	27.34	10.68	1.83	-1.64	-2.57
Tangible Book Value	162.28	58.73	10.06	-9.04	-14.12
Tangible Book Value Per Share	27.34	10.68	1.83	-1.64	-2.57
Land	9.41	9.16	8.87	7.37	7.37
Buildings	42.79	42.79	42.79	42.79	42.79
Machinery	108.4	107.88	107.43	103.32	99.43
Construction In Progress	0.15	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.